782 results on '"Allenbach, Yves"'
Search Results
52. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited
53. Advice in autoimmunity biological diagnosis: guidelines for drafting comments on biological results
54. Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
55. Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
56. Figure S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
57. Table S3 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
58. Data from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
59. A 24-Year-Old Woman With Cough, Arthralgia, and Skin Ulcerations
60. JAK inhibitors for the treatment of adult dermatomyositis: A pilot study
61. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study
62. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression
63. Peculiar clinicopathological features of immune-mediated necrotizing myopathies
64. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
65. Infliximab as effective treatment for aseptic neutrophilic myositis
66. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
67. Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy.
68. Successful outcome under multiple therapy in two cases of anti-MDA5 dermatomyositis with severe cardiomyopathy and interstitial lung disease
69. Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients
70. IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis
71. Antigenic targets in anti-SRP immune-mediated necrotizing myopathy
72. Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19
73. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
74. High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
75. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity
76. Cardiac Adipose Tissue Volume assessed by Computed Tomography is a specific and independent Predictor of Early Mortality and Critical Illness in COVID-19 in type 2-Diabetic Patients
77. Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials
78. 273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023
79. Diagnosis accuracy of muscule MRI for autoimmune myopathies: Multicentricprospective study (DARWIM)
80. Immune Checkpoint Inhibitor–Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution
81. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement
82. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies
83. Activated dendritic cells modulate proliferation and differentiation of human myoblasts
84. Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping
85. Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms
86. Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses
87. Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model
88. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
89. Myostatin in idiopathic inflammatory myopathies: serum assessment and diseaseactivity
90. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
91. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
92. Cytomegalovirus‐induced oral ulcers: A case report and literature review.
93. Prestation de conseil en auto-immunité : aide à la rédaction de commentaires pour les comptes rendus de résultats.
94. Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms.
95. Occurrence of focal myositis during Behçet's disease: The identification of a specific vasculitis-associated focal myopathy.
96. Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses.
97. Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis
98. Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathy
99. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
100. Immune-mediated necrotizing myopathies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.